Prescott Group Capital Management, L.L.C. Guardant Health, Inc. Transaction History

Prescott Group Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$25.44 - $59.78 $2.29 Million - $5.38 Million	90,000 New	90,000 $2.45 Million
Q4 2019 Feb 07, 2020	SELL	$59.49 - $82.78 $416,430 - $579,460	-7,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$62.59 - $110.3 $438,130 - $772,100	7,000 New	7,000 $447,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.8B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Prescott Group Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Prescott Group Capital Management, L.L.C. with notifications on news.